Bortezomib
Buy high quality Bortezomib Impurities from Chemicea Pharma. Chemicea Pharma is one of the
leading manufacturer and exporter of Bortezomib impurities.
We synthesize Bortezomib Degradation Impurities, Bortezomib Process
Impurities, Bortezomib Potential Impurities, Bortezomib USP Related
Compound, Bortezomib N-Nitroso impurities, Bortezomib nitrosamine impurities
etc.
Pharmaceutical Reference Standards
Bortezomib
| CAT. No. | CP-B34000 |
|---|---|
| CAS. No. | 179324-69-7 |
| Mol. F. | C19H25BN4O4 |
| Mol. Wt. | 384.24 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity (R,S-Isomer)
| CAT. No. | CP-B34002 |
|---|---|
| CAS. No. | 1132709-16-0 |
| Mol. F. | C19H25BN4O4 |
| Mol. Wt. | 384.24 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity (R,R-Isomer)
| CAT. No. | CP-B34003 |
|---|---|
| CAS. No. | 1132709-15-9 |
| Mol. F. | C19H25BN4O4 |
| Mol. Wt. | 384.24 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity (S,S-Isomer)
| CAT. No. | CP-B34004 |
|---|---|
| CAS. No. | 1132709-14-8 |
| Mol. F. | C19H25BN4O4 |
| Mol. Wt. | 384.24 |
| Stock Status: | Custom Synthesis |
(S,R)-Bortezomib Hydroxyisopentyl Amide Analog
| CAT. No. | CP-B34005 |
|---|---|
| CAS. No. | 289472-78-2 |
| Mol. F. | C19H24N4O3 |
| Mol. Wt. | 356.42 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 14
| CAT. No. | CP-B34006 |
|---|---|
| CAS. No. | 205393-22-2 |
| Mol. F. | C29H39BN4O4 |
| Mol. Wt. | 518.46 |
| Stock Status: | Custom Synthesis |
Bortezomib USP Related Compound D
| CAT. No. | CP-B34007 |
|---|---|
| CAS. No. | 114457-94-2 |
| Mol. F. | C14H13N3O3 |
| Mol. Wt. | 271.27 |
| Stock Status: | Custom Synthesis |
(S)-Hydroxy Des(boric Acid) Bortezomib
| CAT. No. | CP-B34008 |
|---|---|
| CAS. No. | 289472-81-7 |
| Mol. F. | C19H24N4O3 |
| Mol. Wt. | 356.42 |
| Stock Status: | Custom Synthesis |
Bortezomib USP Related Compound B
| CAT. No. | CP-B34009 |
|---|---|
| CAS. No. | 289472-80-6 |
| Mol. F. | C14H14N4O2 |
| Mol. Wt. | 270.29 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 2 (RR-Isomer)
| CAT. No. | CP-B34011 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H24N4O3 |
| Mol. Wt. | 356.43 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 2 (Mixture of (1S,2R)-Isomer and (1R,2R)-Isomer)
| CAT. No. | CP-B34012 |
|---|---|
| CAS. No. | 2747958-64-9 |
| Mol. F. | C19H24N4O3 |
| Mol. Wt. | 356.43 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 30
| CAT. No. | CP-B34013 |
|---|---|
| CAS. No. | 513-36-0 |
| Mol. F. | C4H9Cl |
| Mol. Wt. | 92.57 |
| Stock Status: | Custom Synthesis |
Bortezomib Related Impurity E
| CAT. No. | CP-B34014 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C20H26N4O3 |
| Mol. Wt. | 370.45 |
| Stock Status: | Custom Synthesis |
Bortezomib Related Impurity F
| CAT. No. | CP-B34015 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C20H26N4O3 |
| Mol. Wt. | 370.45 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity C (Mixture of Isomers)
| CAT. No. | CP-B34016 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H25BN4O4 |
| Mol. Wt. | 384.24 |
| Stock Status: | Custom Synthesis |
Bortezomib Intermediate(R,S)
| CAT. No. | CP-B34017 |
|---|---|
| CAS. No. | 2363753-37-9 |
| Mol. F. | C14H25BO2 |
| Mol. Wt. | 236.16 |
| Stock Status: | Custom Synthesis |
Bortezomib Intermediate(S,R)
| CAT. No. | CP-B34018 |
|---|---|
| CAS. No. | 84110-34-9 |
| Mol. F. | C14H25BO2 |
| Mol. Wt. | 236.16 |
| Stock Status: | Custom Synthesis |
N-(2-pyraziny| carbony|)-D-Phenylalanine
| CAT. No. | CP-B34019 |
|---|---|
| CAS. No. | 1608986-16-8 |
| Mol. F. | C14H13N3O3 |
| Mol. Wt. | 271.28 |
| Stock Status: | Custom Synthesis |
(R)-Hydroperoxy Des(boric Acid) Bortezomib
| CAT. No. | CP-B34020 |
|---|---|
| CAS. No. | 886979-78-8 |
| Mol. F. | C19H24N4O4 |
| Mol. Wt. | 372.42 |
| Stock Status: | Custom Synthesis |
(S)-Hydroperoxy Des(boric Acid) Bortezomib
| CAT. No. | CP-B34021 |
|---|---|
| CAS. No. | 886979-81-3 |
| Mol. F. | C19H24N4O4 |
| Mol. Wt. | 372.42 |
| Stock Status: | Custom Synthesis |
Bortezomib Related Compound E
| CAT. No. | CP-B34022 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C15H14N4O3 |
| Mol. Wt. | 298.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Related Compound K
| CAT. No. | CP-B34023 |
|---|---|
| CAS. No. | NA |
| Mol. F. | 2(C19H24N4O3) |
| Mol. Wt. | 2(356.43) |
| Stock Status: | Custom Synthesis |
Bortezomib Related Compound N
| CAT. No. | CP-B34024 |
|---|---|
| CAS. No. | NA |
| Mol. F. | 2(C19H24N4O3) |
| Mol. Wt. | 2(356.43) |
| Stock Status: | Custom Synthesis |
Bortezomib Related Compound P
| CAT. No. | CP-B34025 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C28H34BN5O5 |
| Mol. Wt. | 531.42 |
| Stock Status: | Custom Synthesis |
Bortezomib R and S Hydroperoxide
| CAT. No. | CP-B34026 |
|---|---|
| CAS. No. | NA |
| Mol. F. | 2(C19H24N4O4) |
| Mol. Wt. | 2(372.4) |
| Stock Status: | Custom Synthesis |
Bortezomib Stereo Isomers Mixture
| CAT. No. | CP-B34027 |
|---|---|
| CAS. No. | NA |
| Mol. F. | 4(C19H25BN4O4) |
| Mol. Wt. | 4(384.2) |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 15
| CAT. No. | CP-B34028 |
|---|---|
| CAS. No. | 1259365-04-2 |
| Mol. F. | C11H24BNO2 |
| Mol. Wt. | 213.13 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 25
| CAT. No. | CP-B34029 |
|---|---|
| CAS. No. | 94242-80-5 |
| Mol. F. | C14H26BNO2 |
| Mol. Wt. | 251.18 |
| Stock Status: | Custom Synthesis |
Desisobutyl-n-butyl Bortezomib
| CAT. No. | CP-B34030 |
|---|---|
| CAS. No. | 1104011-35-9 |
| Mol. F. | C19H25BN4O4 |
| Mol. Wt. | 384.24 |
| Stock Status: | Custom Synthesis |
3-(Chloromethyl)Pyridine
| CAT. No. | CP-B34031 |
|---|---|
| CAS. No. | 3099-31-8 |
| Mol. F. | C6H6ClN |
| Mol. Wt. | 127.57 |
| Stock Status: | Custom Synthesis |
Bortezomib D-Mannitol Ester
| CAT. No. | CP-B34032 |
|---|---|
| CAS. No. | 444576-08-3 |
| Mol. F. | C25H35BN4O8 |
| Mol. Wt. | 530.39 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 4
| CAT. No. | CP-B34033 |
|---|---|
| CAS. No. | 862894-96-0 |
| Mol. F. | C19H22N4O3 |
| Mol. Wt. | 354.4 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 5
| CAT. No. | CP-B34034 |
|---|---|
| CAS. No. | 2379402-85-2 |
| Mol. F. | C19H22N4O4 |
| Mol. Wt. | 370.4 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 9
| CAT. No. | CP-B34035 |
|---|---|
| CAS. No. | 1194235-41-0 |
| Mol. F. | C28H34BN5O5 |
| Mol. Wt. | 531.4 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 10
| CAT. No. | CP-B34036 |
|---|---|
| CAS. No. | 390800-88-1 |
| Mol. F. | C57H69B3N12O9 |
| Mol. Wt. | 1098.7 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 11
| CAT. No. | CP-B34037 |
|---|---|
| CAS. No. | 862895-00-9 |
| Mol. F. | C19H22N4O2 |
| Mol. Wt. | 338.4 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 20
| CAT. No. | CP-B34038 |
|---|---|
| CAS. No. | 89618-77-9 |
| Mol. F. | C14H24BClO2 |
| Mol. Wt. | 270.6 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 21
| CAT. No. | CP-B34039 |
|---|---|
| CAS. No. | 94242-79-2 |
| Mol. F. | C20H42BNO2Si2 |
| Mol. Wt. | 395.6 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 26
| CAT. No. | CP-B34040 |
|---|---|
| CAS. No. | 78-77-3 |
| Mol. F. | C4H9Br |
| Mol. Wt. | 137 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 28
| CAT. No. | CP-B34041 |
|---|---|
| CAS. No. | 18942-49-9 |
| Mol. F. | C14H19NO4 |
| Mol. Wt. | 265.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 29
| CAT. No. | CP-B34042 |
|---|---|
| CAS. No. | 89-01-0 |
| Mol. F. | C6H4N2O4 |
| Mol. Wt. | 168.1 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 31
| CAT. No. | CP-B34043 |
|---|---|
| CAS. No. | 84110-40-7 |
| Mol. F. | C4H11BO2 |
| Mol. Wt. | 101.9 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 32
| CAT. No. | CP-B34044 |
|---|---|
| CAS. No. | 2363753-29-9 |
| Mol. F. | C15H28BNO2 : C2HF3O2 |
| Mol. Wt. | 265.2 : 114.0 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 33
| CAT. No. | CP-B34045 |
|---|---|
| CAS. No. | 948294-96-0 |
| Mol. F. | C14H23BN2O3 |
| Mol. Wt. | 278.2 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity F
| CAT. No. | CP-B34046 |
|---|---|
| CAS. No. | 73058-37-4 |
| Mol. F. | C15H15N3O3 |
| Mol. Wt. | 285.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity H
| CAT. No. | CP-B34047 |
|---|---|
| CAS. No. | 1446194-56-4 |
| Mol. F. | C19H24N4O2 |
| Mol. Wt. | 340.4 |
| Stock Status: | Custom Synthesis |
Bortezomib Amino R Isomer (TFA salt)
| CAT. No. | CP-B34048 |
|---|---|
| CAS. No. | 179324-87-9 |
| Mol. F. | C15H28BNO2 : C2HF3O2 |
| Mol. Wt. | 265.2 : 114.0 |
| Stock Status: | Custom Synthesis |
Bortezomib Isoamyl Impurity
| CAT. No. | CP-B34049 |
|---|---|
| CAS. No. | 1375004-39-9 |
| Mol. F. | C29H39BN4O4 |
| Mol. Wt. | 518.5 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 37
| CAT. No. | CP-B34050 |
|---|---|
| CAS. No. | 1798895-16-5 |
| Mol. F. | C15H15N3O3 |
| Mol. Wt. | 285.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 38
| CAT. No. | CP-B34051 |
|---|---|
| CAS. No. | 18680-27-8 |
| Mol. F. | C10H18O2 |
| Mol. Wt. | 170.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 40
| CAT. No. | CP-B34052 |
|---|---|
| CAS. No. | 85167-14-2 |
| Mol. F. | C15H26BClO2 |
| Mol. Wt. | 284.6 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 41
| CAT. No. | CP-B34053 |
|---|---|
| CAS. No. | 514820-48-5 |
| Mol. F. | C21H44BNO2Si2 |
| Mol. Wt. | 409.6 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 42
| CAT. No. | CP-B34054 |
|---|---|
| CAS. No. | 477254-69-6 |
| Mol. F. | C15H28BNO2 : C2HF3O2 |
| Mol. Wt. | 265.2 : 114.0 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 44
| CAT. No. | CP-B34055 |
|---|---|
| CAS. No. | 2308-61-4 |
| Mol. F. | C18H18N2O2 |
| Mol. Wt. | 294.4 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 45
| CAT. No. | CP-B34056 |
|---|---|
| CAS. No. | 1255646-95-7 |
| Mol. F. | C17H18N2O3 |
| Mol. Wt. | 298.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 46
| CAT. No. | CP-B34057 |
|---|---|
| CAS. No. | 2577-40-4 |
| Mol. F. | C18H20N2O3 |
| Mol. Wt. | 312.4 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 47
| CAT. No. | CP-B34058 |
|---|---|
| CAS. No. | 1194235-14-7 |
| Mol. F. | C23H22N4O4 |
| Mol. Wt. | 418.5 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 53
| CAT. No. | CP-B34059 |
|---|---|
| CAS. No. | 2364553-64-8 |
| Mol. F. | C14H13N3O3 |
| Mol. Wt. | 271.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 54
| CAT. No. | CP-B34060 |
|---|---|
| CAS. No. | 110755-29-8 |
| Mol. F. | C14H22N2O |
| Mol. Wt. | 234.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 56
| CAT. No. | CP-B34061 |
|---|---|
| CAS. No. | 4664-57-7 |
| Mol. F. | C11H16O3S |
| Mol. Wt. | 228.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 71
| CAT. No. | CP-B34062 |
|---|---|
| CAS. No. | 1579304-37-2 |
| Mol. F. | C29H39BN4O4 |
| Mol. Wt. | 518.5 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 78
| CAT. No. | CP-B34063 |
|---|---|
| CAS. No. | 1135491-84-7 |
| Mol. F. | C21H44BNO2Si2 |
| Mol. Wt. | 409.6 |
| Stock Status: | Custom Synthesis |
Bortezomib d-phenylalanyl analog
| CAT. No. | CP-B34064 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C28H34BN5O5 |
| Mol. Wt. | 531.4 |
| Stock Status: | Custom Synthesis |
Hydroxybortezomib
| CAT. No. | CP-B34065 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H25BN4O5 |
| Mol. Wt. | 400.24 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 60
| CAT. No. | CP-B34066 |
|---|---|
| CAS. No. | 2210228-73-0 |
| Mol. F. | C17H27BF3NO3 |
| Mol. Wt. | 361.21 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 77
| CAT. No. | CP-B34067 |
|---|---|
| CAS. No. | 103435-88-7 |
| Mol. F. | C8H6N4O |
| Mol. Wt. | 174.16 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 52
| CAT. No. | CP-B34068 |
|---|---|
| CAS. No. | 87304-47-0 |
| Mol. F. | C15H26BClO2 |
| Mol. Wt. | 284.63 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 51
| CAT. No. | CP-B34069 |
|---|---|
| CAS. No. | 87249-60-3 |
| Mol. F. | C11H17BCl2O2 |
| Mol. Wt. | 262.97 |
| Stock Status: | Custom Synthesis |
Bortezomib impurity 87
| CAT. No. | CP-B34070 |
|---|---|
| CAS. No. | 139442-44-7 |
| Mol. F. | C12H9N3O2 |
| Mol. Wt. | 227.22 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 66
| CAT. No. | CP-B34071 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H24N4O3 |
| Mol. Wt. | 356.43 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 1 (R,S-Isomer)
| CAT. No. | CP-B34072 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C57H69B3N12O9 |
| Mol. Wt. | 1098.68 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 61
| CAT. No. | CP-B34073 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C57H87B3N6O12 |
| Mol. Wt. | 1080.78 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 1 (R,R-Isomer)
| CAT. No. | CP-B34074 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C57H69B3N12O9 |
| Mol. Wt. | 1098.68 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 49
| CAT. No. | CP-B34075 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H24N4O3 |
| Mol. Wt. | 356.43 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 3
| CAT. No. | CP-B34076 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C14H14N4O2 |
| Mol. Wt. | 270.29 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 35
| CAT. No. | CP-B34077 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C28H34BN5O5 |
| Mol. Wt. | 531.42 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 34
| CAT. No. | CP-B34078 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C15H14N4O3 |
| Mol. Wt. | 298.3 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 19
| CAT. No. | CP-B34079 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C28H34BN5O5 |
| Mol. Wt. | 531.42 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 85
| CAT. No. | CP-B34080 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H24N4O4 |
| Mol. Wt. | 372.43 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 84
| CAT. No. | CP-B34081 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H24N4O4 |
| Mol. Wt. | 372.43 |
| Stock Status: | Custom Synthesis |
Bortezomib Impurity 89
| CAT. No. | CP-B34082 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C38H44B2N8O7 |
| Mol. Wt. | 746.44 |
| Stock Status: | Custom Synthesis |
© 2024 Chemicea Limited | All Rights Reserved.
